T1	Participants 997 1071	randomly chosen subset of the randomized patients in the PARTNER IIB trial
T2	Participants 273 347	Placement of Aortic Transcatheter Valves (PARTNER) I and PARTNER II trials
T3	Participants 1455 1566	87 patients assessed for PAR by the consortium could be paired with readings by the PARTNER IIB core laboratory
T4	Participants 568 683	core laboratory of PARTNER IIB was compared with that by a consortium of echocardiography core laboratory directors
